Our Mission: Advancing Clinical Trial Technology
We make software that increases the quantity, value, and development speed of patient treatments.
Our Story: Building the Tool We Wished We Had
When our now-CEO Dema Poppa was running a multicenter medical device clinical trial he found himself frustrated by the lack of tools to take advantage of FDA’s encouragement of remote and risk-based data quality monitoring of trial data.
Though he was spending a large percentage of his budget flying monitors to each of his forty sites, he still was not getting the results he wanted. Mistakes were not caught for months until the on-site visit was scheduled, and sometimes they were not caught at all. He knew there had to be a better way than flying people around the country to access 3-ring binders to compare large data sets.
Dema proposed a solution, which would ultimately set the vision for Invio, at Startup Weekend Health in May of 2015. There, Dema and a small group built a proof-of-concept and validated it with CRAs. The reception was so enthusiastic that after much research, planning, and some additional recruiting, they went on to work full time on solving painful issues for clinical trials by founding Invio in 2016.
In the spring of 2017, Invio was proud to announce the commercial release of SourceDrive®, a secure and compliant cloud-based platform for remote clinical trial management and Source Data Verification.
In the fall of 2017, Invio was chosen for the Cedars-Sinai Accelerator Powered by Techstars, and further expanded the team and the product offering to accommodate larger enterprise customers such as Cedars-Sinai. In the fall of 2018, the team joined Madrona Venture Labs as their first accelerator company, deepening Invio’s commitment to clinical trial automation at a massive scale.
Today, the Invio team works both remotely and from headquarters in the South Lake Union neighborhood of Seattle, Washington, USA. Invio supports many exciting research studies and continues to build additional features for SourceDrive® with a strong emphasis on alleviating the burden of “busy work” from innovative researchers.